| __timestamp | Grifols, S.A. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 1488000000 |
| Thursday, January 1, 2015 | 224193000 | 1525000000 |
| Friday, January 1, 2016 | 197617000 | 2111000000 |
| Sunday, January 1, 2017 | 288320000 | 1848000000 |
| Monday, January 1, 2018 | 240661000 | 1213000000 |
| Tuesday, January 1, 2019 | 276018000 | 1010000000 |
| Wednesday, January 1, 2020 | 294216000 | 997000000 |
| Friday, January 1, 2021 | 354881000 | 967000000 |
| Saturday, January 1, 2022 | 361140000 | 838000000 |
| Sunday, January 1, 2023 | 330551000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Grifols, S.A. have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Teva's R&D expenses have seen a significant decline of approximately 36%, from $1.49 billion to $953 million. This reduction reflects a strategic shift amidst challenging market conditions. In contrast, Grifols has steadily increased its R&D spending by 83%, from $181 million to $331 million, underscoring its commitment to innovation and growth. This divergence highlights the different paths these companies are taking to navigate the competitive landscape. As the pharmaceutical sector continues to face unprecedented challenges, understanding these investment trends provides valuable insights into the future of drug development and market positioning.
R&D Spending Showdown: Merck & Co., Inc. vs Grifols, S.A.
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Summit Therapeutics Inc.
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Viatris Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Vericel Corporation
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
R&D Insights: How Neurocrine Biosciences, Inc. and Grifols, S.A. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Grifols, S.A.
Comparing Innovation Spending: Grifols, S.A. and ADMA Biologics, Inc.